Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001607062-17-000159
Filing Date
2017-04-28
Accepted
2017-04-28 16:08:22
Documents
56
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A rgbp033115form10qa2.htm 10-Q/A 334888
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 7659
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 7586
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 4163
5 EXHIBIT 32.2 ex32_2.htm EX-32.2 4171
  Complete submission text file 0001607062-17-000159.txt   2639330

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE rgbp-20150331.xml EX-101.INS 509259
7 XBRL SCHEMA FILE rgbp-20150331.xsd EX-101.SCH 32900
8 XBRL CALCULATION FILE rgbp-20150331_cal.xml EX-101.CAL 29279
9 XBRL DEFINITION FILE rgbp-20150331_def.xml EX-101.DEF 112111
10 XBRL LABEL FILE rgbp-20150331_lab.xml EX-101.LAB 151456
11 XBRL PRESENTATION FILE rgbp-20150331_pre.xml EX-101.PRE 167201
Mailing Address 4700 SPRING ST #304 LA MESA CA 91942
Business Address 4700 SPRING ST #304 LA MESA CA 91942 619-702-1404
Regen BioPharma Inc (Filer) CIK: 0001589150 (see all company filings)

IRS No.: 455192997 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q/A | Act: 34 | File No.: 333-191725 | Film No.: 17795508
SIC: 2834 Pharmaceutical Preparations